Tag Archives: Public Policy

What is Quality in Medicine? – It Isn’t Easy!

The definition of Quality in Medicine is in the eye of the beholder. There are several good paradigms, but they all look at different components of the overall concept. Continue reading

Posted in General Interest, Policy, Quality | Tagged , | 3 Comments

Providers, Patient Care Delivery and Policy: Hospitalist story

There are often perverse incentives in health care. These incentives can, at times, create competing drives where providers are encouraged to do things that directly increase the costs of care.  Consider the reaction to the mandate to cut down hours … Continue reading

Posted in General Interest, Operational effectiveness, Policy, Quality | Tagged , , | 3 Comments

Who is responsible? Is there Enough Accountability in Medicine?

The Alligator Allegory reads: “ The objective of all dedicated employees should be: To thoroughly analyze all situations, Anticipate all problems prior to their occurrence, Have answers for these problems, And Move swiftly to solve these problems when called upon. … Continue reading

Posted in General Interest, Policy, Quality, Relevant Books | Tagged , | Leave a comment

Medical Ethics should address more than the individual patient encounter

George Lundberg, reviewed what he called the Principles of medical ethics in his blog on  MedPageToday.com on December 20, 2010. He’s done us a service by bringing this up as the season for reflection is upon us. The AMA’s Code … Continue reading

Posted in General Interest, Policy, treatment options | Tagged , | Leave a comment

What is “CE Research/Analysis”? Who should be responsible for it’s implementation?

CE research/analysis is clearly one technique to help gain insight into relative efficacy of several treatments for a specific clinical condition. If the private sector (industry, professional organizations) won’t do it in an unbiased manner, then perhaps an agency such as AHRQ should have our support, counsel and thought. Continue reading

Posted in effectiveness/efficacy, Policy, treatment options | Tagged , , | 3 Comments